<DOC>
	<DOCNO>NCT00197795</DOCNO>
	<brief_summary>To measure serum bactericidal antibody level cell mediate immune response six week dose meningococcal outer membrane vesicle vaccine give 0,6 12 week healthy UK adult .</brief_summary>
	<brief_title>Immunogenicity Reactogenicity Meningococcal B Outer Membrane Vesicle Vaccine Given 0,6,12 Month Schedule Health UK Adults</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Informed write consent give three immunization MenBVac five blood test Between age 18 55 year inclusive recruitment Previous history bacteriologically confirm meningococcal disease History clinically significant allergic sensitivity vaccine receive past Immunodeficiency Any acute chronic systemic illness dependence abuse drug alcohol Language difficulty sufficient preclude adequate comprehension study information Possibility pregnancy Receipt vaccine previous 4 week Receipt group B vaccine past Current participation clinical trial Generalized acute systemic illness and/or temp &gt; 38C day vaccination deferral</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>